A Pan-cancer Screening and Diagnosis Model Based on Abdominal CT Was Established
NCT ID: NCT06614179
Last Updated: 2024-09-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100000 participants
OBSERVATIONAL
2024-07-01
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
NCT05722275
Integrin αvβ6-targeted PET in Malignant Tumors
NCT05835570
CD70-targeted immunoPET Imaging of Kidney Cancer
NCT06680089
Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer
NCT00885248
Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric Cancer
NCT04778345
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* all patients were pathologically diagnosed with abdominal tumors;
* The clinical case data of all patients were complete, and complete follow-up was obtained, with clear information on medical visits, operation time and survival status within 2 years. If the cause of death is unknown, it will be recorded as censored data;
* All patients had no history of active abdominal bleeding, no serious infection or other abdominal diseases that affected the observation of CT imaging within 3 months before surgery.
* Non-tumor population:
* all patients have complete clinical case data, complete abdominal CT, no history of malignant tumors, no serious infections or other abdominal diseases that affect the diagnosis and observation of CT imaging.
Exclusion Criteria
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xiangdong Cheng
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiangdong Cheng
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiangdong Cheng
Role: PRINCIPAL_INVESTIGATOR
Zhejiang Cancer Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
Hangzhou, Zhejiang, China
Zhejiang Cancer Hospital;Cancer hospital of the university of chinese academy of sciences
Hangzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Hu C, Xia Y, Zheng Z, Cao M, Zheng G, Chen S, Sun J, Chen W, Zheng Q, Pan S, Zhang Y, Chen J, Yu P, Xu J, Xu J, Qiu Z, Lin T, Yun B, Yao J, Guo W, Gao C, Kong X, Chen K, Wen Z, Zhu G, Qiao J, Pan Y, Li H, Gong X, Ye Z, Ao W, Zhang L, Yan X, Tong Y, Yang X, Zheng X, Fan S, Cao J, Yan C, Xie K, Zhang S, Wang Y, Zheng L, Wu Y, Ge Z, Tian X, Zhang X, Wang Y, Zhang R, Wei Y, Zhu W, Zhang J, Qiu H, Su M, Shi L, Xu Z, Zhang L, Cheng X. AI-based large-scale screening of gastric cancer from noncontrast CT imaging. Nat Med. 2025 Sep;31(9):3011-3019. doi: 10.1038/s41591-025-03785-6. Epub 2025 Jun 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIT-2024-279
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.